Loss of LKB1 Leads to Alteration of the Immune Microenvironment in Non-Small Cell Lung Cancer
abstract: The majority of non-small cell lung cancer (NSCLC) patients (70%) are diagnosed with adenocarcinoma versus other histological subtypes. These patients often present with advanced, metastatic disease and frequently relapse after treatment. The tumor suppressor, Liver Kinase B1, is frequent...
Other Authors: | Friel, Jacqueline Marie (Author) |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.29807 |
Similar Items
-
A Single-Cell Immune Map of Normal and Cancerous Breast Reveals an Expansion of Phenotypic States Driven by the Tumor Microenvironment
by: Carr, Ambrose James
Published: (2018) -
Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment
by: Aurore Dumond, et al.
Published: (2020-07-01) -
Immune determinants of Barrett’s progression to esophageal adenocarcinoma
by: Kiran H. Lagisetty, et al.
Published: (2021-01-01) -
IL-32γ potentiates tumor immunity in melanoma
by: Thomas Gruber, et al.
Published: (2020-09-01) -
B cells and the Antibody-Dependent Immune Response in Cancer and Infection
by: Lykken, Jacquelyn
Published: (2015)